Abbott (NYSE:ABT) announced today that it launched an upgraded version of its NeuroSphere myPath digital health app.
The Abbott Park, Illinois-based company designed the upgraded app with enhanced functionality to help doctors more closely track their patients as they trial Abbott neurostimulation devices to address their chronic pain.
